Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript May 8, 2024 Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Accelerate Diagnostics Incorporated. First Quarter 2024 Results Conference Call. All participants […]
Q1 2024 Accelerate Diagnostics Inc Earnings Call
Despite a slight revenue increase and reduced operational costs, AXDX faces a growing net loss and strategic hurdles in advancing its WAVE system.